Cg Oncology, Inc.
Clinical trials sponsored by Cg Oncology, Inc., explained in plain language.
-
New virus therapy offers hope for tough bladder cancer cases
Disease control AVAILABLEThis expanded access program provides cretostimogene grenadenorepvec, a virus-based drug, to patients with a type of bladder cancer called non-muscle invasive bladder cancer that has not responded to standard BCG therapy. The drug is designed to infect and destroy cancer cells wh…
Sponsor: CG Oncology, Inc. • Aim: Disease control
Last updated Jun 24, 2026 09:06 UTC
-
Virus therapy takes on bladder cancer: new hope for High-Risk patients
Disease control Recruiting nowThis study tests a new treatment called cretostimogene grenadenorepvec, a virus designed to attack cancer cells, in 325 people with high-risk non-muscle-invasive bladder cancer. The goal is to see if it can make tumors disappear or keep them from coming back. Participants have no…
Phase: PHASE2 • Sponsor: CG Oncology, Inc. • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC